CLARICIN-H Dry Suspension 250 mg/5 mL
Generic Name:
Clarithromycin Oral Suspension 250 mg/5 mL
Therapeutic Group:
Antibacterial
Drug Category:
Macrolide Antibiotic
Content / Composition:
After reconstitution, each 5 mL contains:
Clarithromycin ………………… 250 mg
Excipients …………………… q.s.
(Flavored Pediatric Suspension – Strawberry)
Indications:
CLARICIN-H is indicated for the treatment of susceptible bacterial infections in children, including:
Upper respiratory tract infections (pharyngitis, tonsillitis, sinusitis)
Lower respiratory tract infections (bronchitis, pneumonia)
Acute otitis media
Skin and soft tissue infections
Atypical infections (Mycoplasma, Chlamydia)
Dosage (Pediatric):
General Dose:
7.5 mg/kg twice daily for 5–10 days
Maximum dose:
Up to 500 mg twice daily (as per physician guidance)
Important:
Dose should be adjusted according to body weight and severity of infection
Contraindications:
Hypersensitivity to clarithromycin or macrolides
Severe hepatic impairment with renal dysfunction
History of QT prolongation
Concomitant use with drugs like cisapride, pimozide, ergot derivatives
Administration:
For oral use
Shake well before use
Use calibrated measuring device
May be taken with or without food
Complete full course of therapy
Reconstitution Instructions:
Add recommended amount of clean water
Shake vigorously to form uniform suspension
Drug Interactions:
CYP3A4 inhibitors/substrates (e.g., statins, benzodiazepines)
Warfarin → increased bleeding risk
Theophylline → increased plasma levels
Carbamazepine → toxicity risk
QT-prolonging drugs → arrhythmia risk
Compatibility:
Effective against Gram-positive, Gram-negative, and atypical pathogens
Ideal for respiratory infections
Pediatric-friendly formulation with improved taste
Twice-daily dosing improves compliance
Stability / Storage:
Store dry powder below 25°C
After reconstitution: use within 7–14 days
Keep tightly closed
Protect from light and moisture
Precautions:
Use cautiously in hepatic impairment
Monitor cardiac patients (QT prolongation risk)
Risk of antibiotic resistance with misuse
Observe for allergic reactions
Side Effects:
Common:
Nausea
Diarrhea
Abdominal pain
Uncommon:
Headache
Taste disturbance
Rash
Serious (Rare):
Hepatotoxicity
QT prolongation / arrhythmias
Severe hypersensitivity reactions
Clinical Advantage:
CLARICIN-H offers:
Strong respiratory coverage
Effective against atypical pathogens
Pediatric-friendly taste (Strawberry flavor)
Reliable twice-daily dosing regimen
High tissue penetration for faster recovery
Packaging:
Dry Suspension Bottle (After Reconstitution: 50 mL)
Measuring cup / oral syringe included

CLARICIN-H Dry Suspension 125 mg/5 mL
Generic Name:
Clarithromycin Oral Suspension 125 mg/5 mL
Therapeutic Group:
Antibacterial
Drug Category:
Macrolide Antibiotic
Content / Composition:
After reconstitution, each 5 mL contains:
Clarithromycin ………………… 125 mg
Excipients …………………… q.s.
(Flavored Pediatric Suspension – Strawberry)
Indications:
CLARICIN-H is indicated for pediatric use in the treatment of:
Upper respiratory tract infections (tonsillitis, pharyngitis, sinusitis)
Lower respiratory tract infections (bronchitis, pneumonia)
Acute otitis media
Skin and soft tissue infections
Infections caused by atypical organisms (Mycoplasma, Chlamydia)
Dosage (Pediatric):
Standard Dose:
7.5 mg/kg twice daily for 5–10 days
Alternative (Mild infections):
Lower doses may be used as per physician advice
Important:
Dose should be calculated based on body weight
Use measuring device for accuracy
Contraindications:
Hypersensitivity to clarithromycin or macrolides
Severe hepatic impairment
History of QT prolongation
Concomitant use with ergot derivatives, cisapride, pimozide
Administration:
For oral use only
Shake well before each use
Use measuring cup or oral syringe
Can be taken with or without food
Complete full treatment course
Reconstitution:
Add boiled & cooled water up to mark
Shake well until uniform suspension is formed
Drug Interactions:
CYP3A4 substrates (statins, benzodiazepines)
Warfarin → bleeding risk
Theophylline → increased levels
Carbamazepine → toxicity risk
QT-prolonging drugs → arrhythmia risk
Compatibility:
Effective against Gram-positive, Gram-negative & atypical pathogens
Suitable for pediatric respiratory infections
Pleasant taste improves compliance
Flexible dosing for different age groups
Stability / Storage:
Store below 25°C (dry powder)
After reconstitution: use within 7–14 days
Protect from light and moisture
Keep bottle tightly closed
Precautions:
Use with caution in liver disease
Monitor cardiac patients
Avoid unnecessary antibiotic use
Watch for allergic reactions
Side Effects:
Common:
Nausea
Diarrhea
Abdominal pain
Uncommon:
Headache
Taste disturbance
Skin rash
Serious (Rare):
Hepatotoxicity
QT prolongation
Severe hypersensitivity reactions
Clinical Advantage:
CLARICIN-H 125 mg Suspension provides:
Precise pediatric dosing (low-strength option)
Better tolerability for younger children
Effective respiratory infection control
Pleasant strawberry flavor → high compliance
Reliable twice-daily regimen
Packaging:
Dry Suspension Bottle (After Reconstitution: 50 mL)
Measuring cup / oral syringe included

CEFLOR-H Dry Suspension 250 mg/5 mL
Generic Name:
Cefaclor Oral Suspension 250 mg/5 mL
Therapeutic Group:
Antibacterial
Drug Category:
Second-Generation Cephalosporin Antibiotic
Content / Composition:
After reconstitution, each 5 mL contains:
Cefaclor ………………… 250 mg
Excipients ……………… q.s.
(Flavored Pediatric Suspension – Berry)
Indications:
CEFLOR-H is indicated for the treatment of susceptible bacterial infections in pediatric patients, including:
Upper respiratory tract infections (pharyngitis, tonsillitis, sinusitis)
Lower respiratory tract infections (bronchitis, pneumonia)
Acute otitis media
Skin and soft tissue infections
Urinary tract infections (UTIs)
Dosage (Pediatric):
Standard Dose:
20–40 mg/kg/day divided into 2–3 doses
Severe Infections:
Up to 40 mg/kg/day
Maximum dose:
As directed by physician
Important:
Adjust dose based on weight and severity
Contraindications:
Hypersensitivity to cephalosporins
History of severe allergic reaction to penicillins (cross-reactivity risk)
Administration:
For oral use
Shake well before use
Use measuring device (cup/syringe)
Preferably taken with food (better absorption & tolerance)
Complete full course of therapy
Reconstitution:
Add boiled & cooled water up to mark
Shake thoroughly to form uniform suspension
Drug Interactions:
Anticoagulants → increased bleeding risk
Probenecid → increased cefaclor levels
Nephrotoxic drugs → caution in renal patients
Compatibility:
Broad-spectrum activity against Gram-positive & Gram-negative bacteria
Effective alternative in penicillin-sensitive infections
Suitable for pediatric use
Palatable flavor improves compliance
Stability / Storage:
Store dry powder below 25°C
After reconstitution: use within 7–10 days
Keep tightly closed
Protect from light and moisture
Precautions:
Use cautiously in renal impairment
Monitor for allergic reactions
Risk of antibiotic-associated diarrhea
Avoid misuse to prevent resistance
Side Effects:
Common:
Diarrhea
Nausea
Abdominal discomfort
Uncommon:
Rash
Headache
Vomiting
Serious (Rare):
Hypersensitivity reactions
Stevens-Johnson syndrome
Pseudomembranous colitis
Clinical Advantage:
CEFLOR-H provides:
Reliable cephalosporin coverage
Effective pediatric respiratory & ENT infection control
Good tolerability profile
Flexible dosing (2–3 times daily)
Pleasant berry flavor → improved compliance
Packaging:
Dry Suspension Bottle (After Reconstitution: 30 mL)
Measuring cup / oral syringe included

[12:19 AM, 4/29/2026] +93 79 666 5158: CLARICIN-H Dry Suspension 125 mg/5 mL
Generic Name:
Clarithromycin Oral Suspension 125 mg/5 mL
Therapeutic Group:
Antibacterial
Drug Category:
Macrolide Antibiotic
Content / Composition:
After reconstitution, each 5 mL contains:
Clarithromycin ………………… 125 mg
Excipients …………………… q.s.
(Flavored Pediatric Suspension – Strawberry)
Indications:
CLARICIN-H is indicated for pediatric use in the treatment of:
Upper respiratory tract infections (tonsillitis, pharyngitis, sinusitis)
Lower respiratory tract infections (bronchitis, pneumonia)
Acute otitis media
Skin and soft tissue infections
Infections caused by atypical organisms (Mycoplasma, Chlamydia)
Dosage (Pediatric):
Standard Dose:
7.5 mg/kg twice daily for 5–10 days
Alternative (Mild infections):
Lower doses ma…
[12:20 AM, 4/29/2026] +93 79 666 5158: CEFLOR-H Dry Suspension 250 mg/5 mL
Generic Name:
Cefaclor Oral Suspension 250 mg/5 mL
Therapeutic Group:
Antibacterial
Drug Category:
Second-Generation Cephalosporin Antibiotic
Content / Composition:
After reconstitution, each 5 mL contains:
Cefaclor ………………… 250 mg
Excipients ……………… q.s.
(Flavored Pediatric Suspension – Berry)
Indications:
CEFLOR-H is indicated for the treatment of susceptible bacterial infections in pediatric patients, including:
Upper respiratory tract infections (pharyngitis, tonsillitis, sinusitis)
Lower respiratory tract infections (bronchitis, pneumonia)
Acute otitis media
Skin and soft tissue infections
Urinary tract infections (UTIs)
Dosage (Pediatric):
Standard Dose:
20–40 mg/kg/day divided into 2–3 doses
Severe Infections:
Up to 4…
[12:22 AM, 4/29/2026] +93 79 666 5158: CEFLOR-H Dry Suspension 125 mg/5 mL
Generic Name:
Cefaclor Oral Suspension 125 mg/5 mL
Therapeutic Group:
Antibacterial
Drug Category:
Second-Generation Cephalosporin Antibiotic
Content / Composition:
After reconstitution, each 5 mL contains:
Cefaclor ………………… 125 mg
Excipients ……………… q.s.
(Flavored Pediatric Suspension – Orange / Banana)
Indications:
CEFLOR-H is indicated for pediatric patients in the treatment of:
Upper respiratory tract infections (pharyngitis, tonsillitis, sinusitis)
Lower respiratory tract infections (bronchitis, pneumonia)
Acute otitis media
Skin and soft tissue infections
Urinary tract infections (UTIs)
Dosage (Pediatric):
Standard Dose:
20–40 mg/kg/day divided into 2–3 doses
Mild Infections:
20 mg/kg/day
Severe Infections:
Up to 40 mg/kg/day
Important:
Dose should be calculated based on body weight
Use measuring device for accuracy
Contraindications:
Hypersensitivity to cephalosporins
History of severe allergy to penicillins (cross-reactivity risk)
Administration:
For oral use
Shake well before each use
Use measuring cup or oral syringe
Preferably taken with food
Complete full course of therapy
Reconstitution:
Add boiled & cooled water up to mark
Shake well to obtain uniform suspension
Drug Interactions:
Anticoagulants → increased bleeding risk
Probenecid → increases cefaclor levels
Nephrotoxic drugs → caution in renal impairment
Compatibility:
Broad-spectrum antibacterial coverage
Effective in pediatric ENT & respiratory infections
Good tolerability profile
Pleasant flavor improves adherence in children
Stability / Storage:
Store dry powder below 25°C
After reconstitution: use within 7–10 days
Keep tightly closed
Protect from light and moisture
Precautions:
Use cautiously in renal impairment
Monitor for allergic reactions
Risk of antibiotic-associated diarrhea
Avoid unnecessary or prolonged use
Side Effects:
Common:
Diarrhea
Nausea
Abdominal discomfort
Uncommon:
Skin rash
Headache
Vomiting
Serious (Rare):
Hypersensitivity reactions
Stevens-Johnson syndrome
Pseudomembranous colitis
Clinical Advantage:
CEFLOR-H 125 mg Suspension provides:
Precise low-dose pediatric option
Better tolerability for younger children
Effective respiratory & ENT infection control
Flexible dosing (2–3 times daily)
Child-friendly taste (Orange/Banana)
Packaging:
Dry Suspension Bottle (After Reconstitution: 30 mL)
Measuring cup / oral syringe included

ZUROXIM Tablets (Cefuroxime + Clavulanic Acid)
Generic Name:
Cefuroxime Axetil + Clavulanic Acid Tablets
Strength:
Cefuroxime 250 mg + Clavulanic Acid 125 mg
Therapeutic Group:
Antibacterial
Drug Category:
Second-Generation Cephalosporin + Beta-Lactamase Inhibitor
Content / Composition:
Each film-coated tablet contains:
Cefuroxime Axetil …………… 250 mg
Clavulanic Acid ……………… 125 mg
Excipients …………………… q.s.
Indications:
ZUROXIM is indicated for the treatment of susceptible bacterial infections including:
Upper respiratory tract infections (sinusitis, pharyngitis, tonsillitis)
Lower respiratory tract infections (bronchitis, pneumonia)
Urinary tract infections (UTIs)
Skin and soft tissue infections
Ear infections (otitis media)
Dental infections
Infections caused by beta-lactamase producing organisms
Dosage:
Adults & Adolescents:
1 tablet twice daily (every 12 hours)
Severe infections:
Dose may be adjusted as per physician
Duration:
Usually 5–10 days depending on infection
Contraindications:
Hypersensitivity to cephalosporins or beta-lactam antibiotics
History of severe allergic reaction to penicillins
Severe hepatic dysfunction related to clavulanate use
Administration:
Oral use only
Take after food for better absorption
Swallow whole with water
Complete full prescribed course
Drug Interactions:
Probenecid → increases cefuroxime levels
Anticoagulants → increased bleeding risk
Oral contraceptives → reduced effectiveness
Nephrotoxic drugs → caution
Compatibility / Clinical Benefits:
Broad-spectrum antibacterial activity
Effective against beta-lactamase producing bacteria
Enhanced efficacy in resistant infections
Suitable for respiratory & mixed infections
Reliable oral alternative to injectable therapy
Stability / Storage:
Store below 25°C
Protect from moisture and light
Keep in original packaging
Precautions:
Use with caution in renal impairment
Monitor liver function in prolonged use
Risk of antibiotic-associated colitis
Avoid unnecessary prolonged therapy
Side Effects:
Common:
Diarrhea
Nausea
Abdominal discomfort
Uncommon:
Headache
Skin rash
Elevated liver enzymes
Serious (Rare):
Hypersensitivity reactions
Stevens-Johnson syndrome
Hepatic dysfunction
Clinical Advantage:
ZUROXIM provides:
Dual mechanism (Antibiotic + Enzyme inhibitor)
Stronger action against resistant bacteria
Improved treatment outcomes in mixed infections
Excellent choice for respiratory & ENT infections
Packaging:
6 × 2 Tablets (Blister Pack)
Film-Coated Tablets

ZUROXIM 625 mg Tablets
(Cefuroxime 500 mg + Clavulanic Acid 125 mg)
Generic Name:
Cefuroxime Axetil + Clavulanic Acid
Therapeutic Group:
Antibacterial
Drug Category:
Second-Generation Cephalosporin + Beta-Lactamase Inhibitor
Content / Composition:
Each film-coated tablet contains:
Cefuroxime Axetil …………… 500 mg
Clavulanic Acid ……………… 125 mg
Excipients …………………… q.s.
Indications:
ZUROXIM 625 mg is indicated for moderate to severe bacterial infections including:
Upper respiratory tract infections (sinusitis, tonsillitis, pharyngitis)
Lower respiratory infections (acute bronchitis, pneumonia)
Urinary tract infections (complicated & uncomplicated)
Skin and soft tissue infections
Ear infections (otitis media)
Dental infections
Bone and joint infections
Infections caused by beta-lactamase producing organisms
Dosage:
Adults:
1 tablet twice daily (every 12 hours)
Severe infections:
May require higher dose or physician adjustment
Duration:
Typically 5–10 days depending on infection severity
Contraindications:
Hypersensitivity to cephalosporins, penicillins, or beta-lactam antibiotics
History of severe allergic reactions (anaphylaxis)
Severe hepatic dysfunction associated with clavulanate
Administration:
Oral administration
Take with food to improve absorption and reduce GI upset
Swallow whole with water
Do not skip doses — complete full course
Drug Interactions:
Probenecid → increases cefuroxime levels
Anticoagulants (e.g., warfarin) → increased bleeding risk
Oral contraceptives → reduced efficacy
Nephrotoxic drugs → caution required
Compatibility / Clinical Benefits:
Broad-spectrum antibacterial coverage
Effective against resistant beta-lactamase producing bacteria
Dual-action mechanism enhances efficacy
Suitable for severe and mixed infections
Reliable oral alternative to injectable antibiotics
Stability / Storage:
Store below 25°C
Protect from moisture and direct light
Keep in original packaging
Precautions:
Use cautiously in renal impairment (dose adjustment required)
Monitor liver function in prolonged therapy
Risk of antibiotic-associated colitis
Avoid unnecessary prolonged use to prevent resistance
Side Effects:
Common:
Diarrhea
Nausea
Abdominal discomfort
Uncommon:
Headache
Skin rash
Elevated liver enzymes
Serious (Rare):
Hypersensitivity reactions
Stevens-Johnson Syndrome
Hepatic dysfunction
Clinical Advantages:
ZUROXIM 625 mg provides:
High-strength broad-spectrum coverage
Enhanced activity against resistant pathogens
Rapid infection control
Ideal for moderate to severe infections
Packaging:
6 × 2 Tablets (Blister Pack)
Film-Coated Tablets

SUBMOX 1 g Tablets
(Amoxicillin 1000 mg)
Generic Name:
Amoxicillin
Therapeutic Group:
Antibacterial
Drug Category:
Aminopenicillin (Beta-Lactam Antibiotic)
Content / Composition:
Each film-coated tablet contains:
Amoxicillin (as Amoxicillin Trihydrate) ……… 1000 mg
Excipients ………………………………………… q.s.
Indications:
SUBMOX is indicated for the treatment of susceptible bacterial infections including:
Upper respiratory tract infections (pharyngitis, tonsillitis, sinusitis)
Lower respiratory infections (bronchitis, pneumonia)
Urinary tract infections (UTIs)
Skin and soft tissue infections
Ear infections (otitis media)
Dental infections
Gastrointestinal infections (including H. pylori as part of combination therapy)
Dosage:
Adults:
500 mg to 1000 mg every 8–12 hours depending on severity
Severe infections:
Higher doses may be required under physician supervision
Duration:
Typically 5–10 days
Contraindications:
Hypersensitivity to penicillins or beta-lactam antibiotics
History of severe allergic reactions (e.g., anaphylaxis)
Infectious mononucleosis (risk of rash)
Administration:
Oral use
Can be taken with or without food
Swallow with a full glass of water
Complete full course to prevent resistance
Drug Interactions:
Probenecid → increases amoxicillin levels
Oral contraceptives → reduced effectiveness
Allopurinol → increased risk of rash
Anticoagulants → monitor INR
Compatibility / Clinical Benefits:
Broad-spectrum antibacterial coverage
Effective against Gram-positive and some Gram-negative bacteria
Well tolerated and widely used first-line antibiotic
Suitable for community-acquired infections
Flexible dosing options
Stability / Storage:
Store below 25°C
Protect from moisture and light
Keep in original packaging
Precautions:
Use with caution in renal impairment (dose adjustment required)
Monitor for allergic reactions
Prolonged use may lead to superinfection
Use only for confirmed bacterial infections
Side Effects:
Common:
Nausea
Diarrhea
Skin rash
Uncommon:
Vomiting
Abdominal discomfort
Serious (Rare):
Anaphylaxis
Stevens-Johnson Syndrome
Antibiotic-associated colitis
Clinical Advantages:
SUBMOX 1 g provides:
High-dose rapid antibacterial action
Reliable first-line therapy
Effective in respiratory & ENT infections
Flexible use in combination therapies (e.g., H. pylori)
Packaging:
1 × 12 Tablets (Blister Pack)
Film-Coated Tablets

SUBMOX 500 mg Capsules
(Amoxicillin 500 mg)
Generic Name:
Amoxicillin
Therapeutic Group:
Antibacterial
Drug Category:
Aminopenicillin (Beta-Lactam Antibiotic)
Content / Composition:
Each capsule contains:
Amoxicillin (as Amoxicillin Trihydrate) ……… 500 mg
Excipients ………………………………………… q.s.
Indications:
SUBMOX 500 mg is indicated for the treatment of:
Upper respiratory tract infections (pharyngitis, tonsillitis, sinusitis)
Lower respiratory infections (bronchitis, pneumonia)
Urinary tract infections (UTIs)
Skin and soft tissue infections
Ear infections (otitis media)
Dental infections
Gastrointestinal infections (including H. pylori in combination therapy)
Dosage:
Adults & Adolescents:
500 mg every 8 hours
یا
500–1000 mg every 12 hours
Severe infections:
Dose may be increased under physician supervision
Duration:
Usually 5–10 days
Contraindications:
Hypersensitivity to penicillins or beta-lactam antibiotics
History of anaphylaxis to antibiotics
Infectious mononucleosis (risk of rash)
Administration:
Oral use
Can be taken with or without food
Swallow capsule with water
Complete full treatment course
Drug Interactions:
Probenecid → increases plasma levels
Allopurinol → increased risk of rash
Oral contraceptives → reduced effectiveness
Anticoagulants → monitor INR
Compatibility / Clinical Benefits:
Broad-spectrum antibacterial activity
Effective against Gram-positive and some Gram-negative bacteria
First-line therapy for many common infections
Good safety profile
Flexible dosing regimen
Stability / Storage:
Store below 25°C
Protect from moisture
Keep in original packaging
Precautions:
Use cautiously in renal impairment
Monitor for hypersensitivity reactions
Long-term use may cause superinfection
Avoid misuse to prevent resistance
Side Effects:
Common:
Nausea
Diarrhea
Mild rash
Uncommon:
Vomiting
Abdominal pain
Serious (Rare):
Anaphylaxis
Stevens-Johnson Syndrome
Antibiotic-associated colitis
Clinical Advantages:
SUBMOX 500 mg provides:
Reliable first-line antibiotic therapy
Effective in community infections
Fast symptom relief
Widely trusted safety profile
Packaging:
10 × 2 Capsules (Blister Pack)

CEFNUS 200 mg Capsules
(Cefixime 200 mg)
Generic Name:
Cefixime
Therapeutic Group:
Antibacterial
Drug Category:
Third-Generation Cephalosporin Antibiotic
Content / Composition:
Each capsule contains:
Cefixime ………………………………… 200 mg
Excipients ……………………………… q.s.
Indications:
CEFNUS is indicated for the treatment of susceptible bacterial infections including:
Upper respiratory tract infections (pharyngitis, tonsillitis, sinusitis)
Lower respiratory tract infections (bronchitis)
Urinary tract infections (UTIs)
Ear infections (otitis media)
Typhoid fever
Uncomplicated gonorrhea
Gastrointestinal infections
Dosage:
Adults & Adolescents:
200 mg twice daily
یا
400 mg once daily
Duration:
Usually 5–10 days depending on infection
Contraindications:
Hypersensitivity to cephalosporins or beta-lactam antibiotics
History of severe allergic reactions to penicillins
Administration:
Oral use
Can be taken with or without food
Swallow capsule with water
Complete full prescribed course
Drug Interactions:
Anticoagulants → increased bleeding risk
Carbamazepine → increased levels
Probenecid → may increase cefixime levels
Compatibility / Clinical Benefits:
Broad-spectrum antibacterial activity
Effective against Gram-positive and Gram-negative bacteria
High stability against beta-lactamase enzymes
Convenient once-daily dosing option
Ideal for outpatient therapy
Stability / Storage:
Store below 25°C
Protect from moisture and light
Keep in original packaging
Precautions:
Use with caution in renal impairment
Monitor for allergic reactions
Risk of antibiotic-associated colitis
Avoid unnecessary prolonged use
Side Effects:
Common:
Diarrhea
Nausea
Abdominal pain
Uncommon:
Headache
Dizziness
Skin rash
Serious (Rare):
Hypersensitivity reactions
Stevens-Johnson Syndrome
Severe diarrhea (C. difficile-associated)
Clinical Advantages:
CEFNUS 200 mg provides:
Advanced third-generation antibiotic coverage
Effective against resistant organisms
Convenient dosing (once daily option)
Strong choice for respiratory & systemic infections
Packaging:
10 × 1 Capsules (Blister Pack)

CEFNUS 400 mg Capsules
(Cefixime 400 mg)
Generic Name:
Cefixime
Therapeutic Group:
Antibacterial
Drug Category:
Third-Generation Cephalosporin Antibiotic
Content / Composition:
Each capsule contains:
Cefixime ………………………………… 400 mg
Excipients ……………………………… q.s.
Indications:
CEFNUS 400 mg is indicated for the treatment of moderate to severe bacterial infections including:
Upper respiratory tract infections (pharyngitis, tonsillitis, sinusitis)
Lower respiratory infections (acute & chronic bronchitis)
Urinary tract infections (UTIs)
Ear infections (otitis media)
Typhoid fever
Uncomplicated gonorrhea
Gastrointestinal infections
Dosage:
Adults & Adolescents:
400 mg once daily
یا
200 mg twice daily
Duration:
Typically 5–10 days
Typhoid fever: 7–14 days (as per physician)
Contraindications:
Hypersensitivity to cephalosporins or beta-lactam antibiotics
History of severe allergic reactions
Administration:
Oral use
Can be taken with or without food
Swallow capsule with water
Complete full prescribed course
Drug Interactions:
Anticoagulants → increased bleeding risk
Carbamazepine → increased plasma levels
Probenecid → may increase cefixime concentration
Compatibility / Clinical Benefits:
Broad-spectrum antibacterial activity
Strong efficacy against Gram-negative pathogens
High resistance to beta-lactamase enzymes
Convenient once-daily dosing
Ideal for outpatient and step-down therapy
Stability / Storage:
Store below 25°C
Protect from moisture and light
Keep in original packaging
Precautions:
Use with caution in renal impairment
Monitor for allergic reactions
Risk of antibiotic-associated diarrhea/colitis
Avoid prolonged or unnecessary use
Side Effects:
Common:
Diarrhea
Nausea
Abdominal pain
Uncommon:
Headache
Dizziness
Skin rash
Serious (Rare):
Hypersensitivity reactions
Stevens-Johnson Syndrome
Severe colitis (C. difficile)
Clinical Advantages:
CEFNUS 400 mg provides:
High-strength third-generation antibiotic therapy
Convenient once-daily dosing improves compliance
Effective against resistant and complicated infections
Strong choice for respiratory & systemic infections
Packaging:
1 × 5 Capsules (Blister Pack)